# BridgeBio Pharma, Inc. (BBIO): Dividend & Fundamentals

> Markdown mirror of https://www.dividenddata.com/stocks/bbio for AI agents. Same live data as the HTML page, regenerated on the same refresh cycle. Not investment advice.

- Sector: Healthcare · Industry: Biotechnology
- Exchange: NASDAQ · Trading currency: USD

BridgeBio Pharma, Inc. is a pharmaceutical company dedicated to identifying, advancing, and providing medical solutions for various genetic conditions. The firm boasts an extensive portfolio comprising 30 distinct development initiatives, spanning the entire spectrum from initial discovery research to advanced clinical trial phases. Notable candidates within its development pipeline include: AG10 and BBP-265: A small molecule designed to stabilize transthyretin (TTR), currently in a pivotal Phase 3 clinical trial targeting transthyretin amyloidosis-cardiomyopathy (ATTR-CM). BBP-831: A selec...

## Quote & Key Metrics

As of 2026-10-22:

| Metric | Value |
|---|---|
| Price | $68.12 USD |
| Market Cap | $13.32B |
| P/E (TTM) | — |
| EPS (TTM) | −$3.57 |
| 52-Week Range | $52.75 – $93.42 |
| Dividend Yield (TTM) | — |

## Dividend

BBIO has no dividend payment history in our records.

## Frequently Asked Questions

### What does BridgeBio Pharma, Inc. do?

BridgeBio Pharma, Inc. (BBIO) operates in the Biotechnology industry within the Healthcare sector. Full company description, peers, and segment breakdown are on the page above.

### What is BBIO's market cap?

BridgeBio Pharma, Inc. (BBIO) has a market capitalization of approximately $13.32 billion, as of October 22, 2026, based on the most recent share price and shares outstanding.

### Does BBIO pay a dividend?

No, BridgeBio Pharma, Inc. (BBIO) does not currently pay a regular dividend. Many growth-stage companies reinvest earnings into the business instead of returning capital to shareholders. The Dividend tab tracks any future declarations.

### Is BBIO profitable?

BridgeBio Pharma, Inc. (BBIO) currently reports negative earnings on a trailing-twelve-month basis. The Earnings and Financials tabs show the full EPS history, revenue trend, and analyst forecasts for future profitability.

### Has BBIO ever paid a dividend?

No. Dividend Data's records show no dividend payments from BridgeBio Pharma, Inc. (BBIO). A first dividend would appear on the Dividend tab once it is declared.

## More on Dividend Data

- Overview (HTML): https://www.dividenddata.com/stocks/bbio
- Dividend history & safety: https://www.dividenddata.com/stocks/bbio/dividend
- Earnings & EPS: https://www.dividenddata.com/stocks/bbio/earnings
- Financial statements: https://www.dividenddata.com/stocks/bbio/financials/income
- Valuation multiples: https://www.dividenddata.com/stocks/bbio/valuation
- Peer comparison: https://www.dividenddata.com/stocks/bbio/peers

Data sourced from primary filings and market data providers; see https://www.dividenddata.com/methodology.